# OnCo record raise (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/raise/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "raise", "NCT01183780" ;
  schema:name "RAISE"@en ;
  schema:description "Switching from one blood-vessel drug to another after progression gave about six extra weeks, the same small gain as aflibercept."@en ;
  schema:url <https://onco.cc/trials/raise/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01183780>, <https://doi.org/10.1016/S1470-2045(15)70127-0> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/antiangiogenic/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/ramucirumab/>, <https://onco.cc/drugs/folfiri/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> ;
  onco:trials <https://onco.cc/trials/velour/> .